Promega Corp. is building a new cGMP facility to support regulated product manufacturing for its customers who need FDA-regulated molecular biology products. These include components such as sample preparation systems and reagents.

The 260,000-sq.-ft. facility will employ an additional 100 people in the next five years. Most of the building will be dedicated to manufacturing for fixed production lines as well as flexible manufacturing areas.

“Molecular biology opens doors not only to new understanding of life, but to practical applications that enhance the health of our citizens,” said chief executive officer Bill Linton. “We have a tremendous team at Promega who continue to diversify our capabilities to support the needs of our customers. This building is our next step in expanding our product supply capabilities worldwide.”